// App-Quantinova.ai

P017 : Prescription trends and reasons for discontinuation amongst at-home biological therapies

Researchers

Presenter

  • Mark D J Gibson

Principal Investigators

  • Jacob Wells

  • Sujith Subesinghe

Medical Centers

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Aspartate aminotransferase

  • Alanine transaminase

  • Creatinine

  • Human albumin

Drug/Treatment

  • Certolizumab pegol

  • Adalimumab

  • Etanercept

  • CHS-0214

  • golimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved